[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR9507678A - Construção de dna vetor de expressão recombinante célula proceso para produzir uma enzima enzima preparação de enzima uso da enzima e cultura - Google Patents

Construção de dna vetor de expressão recombinante célula proceso para produzir uma enzima enzima preparação de enzima uso da enzima e cultura

Info

Publication number
BR9507678A
BR9507678A BR9507678A BR9507678A BR9507678A BR 9507678 A BR9507678 A BR 9507678A BR 9507678 A BR9507678 A BR 9507678A BR 9507678 A BR9507678 A BR 9507678A BR 9507678 A BR9507678 A BR 9507678A
Authority
BR
Brazil
Prior art keywords
enzyme
culture
construction
produce
expression vector
Prior art date
Application number
BR9507678A
Other languages
English (en)
Inventor
Lene Venke Kofod
Lene Nonboe Andersen
Markus Sakari Kauppinen
Stephan Christgau
Henrik Dalboge
Hans Seir Olsen
Jens Breinholt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9507678A publication Critical patent/BR9507678A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D8/00—Methods for preparing or baking dough
    • A21D8/02—Methods for preparing dough; Treating dough prior to baking
    • A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38645—Preparations containing enzymes, e.g. protease or amylase containing cellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/244—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01006—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
    • D06M16/003—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic with enzymes or microorganisms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Textile Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9507678A 1994-05-11 1995-05-11 Construção de dna vetor de expressão recombinante célula proceso para produzir uma enzima enzima preparação de enzima uso da enzima e cultura BR9507678A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK54694 1994-05-11
PCT/DK1995/000188 WO1995031533A1 (en) 1994-05-11 1995-05-11 AN ENZYME WITH ENDO-1,3(4)-β-GLUCANASE ACTIVITY

Publications (1)

Publication Number Publication Date
BR9507678A true BR9507678A (pt) 1997-09-23

Family

ID=8094773

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507678A BR9507678A (pt) 1994-05-11 1995-05-11 Construção de dna vetor de expressão recombinante célula proceso para produzir uma enzima enzima preparação de enzima uso da enzima e cultura

Country Status (7)

Country Link
US (2) US5871966A (pt)
EP (1) EP0759073A1 (pt)
AU (1) AU2445795A (pt)
BR (1) BR9507678A (pt)
HU (1) HUT75368A (pt)
RU (1) RU2215034C2 (pt)
WO (1) WO1995031533A1 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882131A1 (en) * 1996-02-09 1998-12-09 Novo Nordisk Biotech, Inc. Polypeptides having mutanase activity and nucleic acids encoding same
US5783537A (en) * 1996-03-05 1998-07-21 Kay Chemical Company Enzymatic detergent composition and method for degrading and removing bacterial cellulose
EP1011620A1 (en) 1996-10-11 2000-06-28 Novo Nordisk A/S CELLULOSE BINDING DOMAINS (CBDs) FOR ORAL CARE PRODUCTS
AU5853098A (en) * 1997-02-14 1998-09-08 Novo Nordisk A/S An enzyme with endo-1,3(4)-beta-glucanase activity
US20030124596A1 (en) * 2001-11-07 2003-07-03 Millennium Pharmaceuticals, Inc. Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
US20050180964A1 (en) * 2003-03-17 2005-08-18 Puntenney Steven B. Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species
US20050220846A1 (en) * 2004-04-05 2005-10-06 Puntenney Steven B Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
CA2912012C (en) * 2005-05-05 2018-05-29 Sensient Flavors Inc. Production of beta-glucans and mannans
BRPI0503756A (pt) * 2005-09-06 2007-05-15 Gold Nutrition Pesquisa Desenv método de processamento de soja pelo uso de enzima especìfica, pó de soja processada e lìquido de soja processada
US8142798B2 (en) 2006-04-26 2012-03-27 OmniGen Research, L.L.C. Augmentation of titer for vaccination in animals
WO2009085743A1 (en) * 2007-12-20 2009-07-09 Danisco Us Inc., Genencor Division Enzymatic prevention and control of biofilm
CA2744987C (en) 2008-12-02 2018-01-16 Chiralgen, Ltd. Method for the synthesis of phosphorus atom modified nucleic acids
CN102596204B (zh) 2009-07-06 2016-11-23 波涛生命科学有限公司 新的核酸前药及其使用方法
WO2012039448A1 (ja) 2010-09-24 2012-03-29 株式会社キラルジェン 不斉補助基
JP6128529B2 (ja) 2011-07-19 2017-05-17 ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． 官能化核酸の合成のための方法
US9683224B2 (en) 2011-09-14 2017-06-20 Dupont Nutrition Biosciences Aps Enzymes
CN107011400B (zh) 2012-07-13 2021-05-25 波涛生命科学有限公司 不对称辅助基团
EP4219516A3 (en) 2012-07-13 2024-01-10 Wave Life Sciences Ltd. Chiral control
RU2677639C2 (ru) 2012-07-13 2019-01-18 Шин Ниппон Биомедикал Лэбораториз, Лтд. Хиральный адъювант нуклеиновой кислоты
US20150337247A1 (en) 2012-08-03 2015-11-26 Dupont Nutrition Biosciences Aps Enzymes
US9615595B2 (en) 2013-03-05 2017-04-11 Mera Technology International Inc. Method and apparatus for wasteless homogenized soybean beverage production
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
US10149905B2 (en) 2014-01-15 2018-12-11 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having antitumor effect and antitumor agent
WO2015108047A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
SG10201912897UA (en) 2014-01-16 2020-02-27 Wave Life Sciences Ltd Chiral design
US20150209416A1 (en) * 2014-01-27 2015-07-30 OmniGen Resarch, LLC Composition and method for co-administration with a growth promotant
PT3110437T (pt) * 2014-02-12 2018-01-16 Omnigen Res Llc Composição e método para promover a redução do stress térmico em animais
CN104207958A (zh) * 2014-08-26 2014-12-17 华南理工大学 一种含有复合酶有效清除牙菌斑的假牙护理液及其制备方法
CN104207983B (zh) * 2014-08-26 2017-08-25 华南理工大学 一种含酶与陈皮提取物的假牙护理液及其制备方法
CN104188861A (zh) * 2014-08-26 2014-12-10 华南理工大学 一种消减牙菌斑的复合酶漱口液及其制备方法
EP3017706A1 (en) 2014-11-05 2016-05-11 Dupont Nutrition Biosciences ApS Enzymes for malting
WO2017044832A1 (en) * 2015-09-09 2017-03-16 Omnigen Research, Llc A composition and/or combination for aquaculture
CA3127167A1 (en) * 2019-03-14 2020-09-17 The Procter & Gamble Company Cleaning compositions comprising enzymes
CA3127171A1 (en) * 2019-03-14 2020-09-17 The Procter & Gamble Company Method for treating cotton
EP3938502A1 (en) * 2019-03-14 2022-01-19 The Procter & Gamble Company Cleaning compositions comprising enzymes
US20230012672A1 (en) 2019-09-16 2023-01-19 Novozymes A/S Polypeptides having beta-glucanase activity and polynucleotides encoding same
KR20240029582A (ko) * 2022-08-24 2024-03-06 씨제이제일제당 (주) 글루카나제 활성을 갖는 신규 폴리펩티드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK41992D0 (pt) * 1992-03-27 1992-03-27 Novo Nordisk As
KR100303619B1 (ko) * 1992-10-06 2001-11-22 피아 스타르 셀룰라제변이체
DK81293D0 (da) * 1993-07-06 1993-07-06 Novo Nordisk As Enzym

Also Published As

Publication number Publication date
US5871966A (en) 1999-02-16
EP0759073A1 (en) 1997-02-26
RU2215034C2 (ru) 2003-10-27
HU9603117D0 (en) 1997-01-28
US6140096A (en) 2000-10-31
WO1995031533A1 (en) 1995-11-23
AU2445795A (en) 1995-12-05
HUT75368A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
BR9507678A (pt) Construção de dna vetor de expressão recombinante célula proceso para produzir uma enzima enzima preparação de enzima uso da enzima e cultura
BR8302318A (pt) Ativador de plasminogenio de tecido humano,seguencia de dna,vetor de expressao replicavel,plasmideo,microorganismo ou cultura celulor,composicao,uso do dito ativador,processo de expressao,e processo para produzir t pa humano
AU2722997A (en) Influenza virus replicated in mammalian cell culture and vaccine production
NO864990D0 (no) Solubilisering av proteinaggregater.
BR9509525A (pt) Construção de dna vetor de expressão recombinante célula processo para produzir a enzima que exibe atividade lipolítica enzima que exibe atividade lipolítica preparação de enzima aditivo de detergente e composição de detergente
EP0927270A4 (en) PRESERVATION OF DNA AND RNA BY LYOPHILIZATION OF CULTIVATED HUMAN CELLS
FI972821A0 (fi) Geneettisesti ohjatun solukuoleman geenit ja proteiinit
BR9407767A (pt) Variante de enzima &-amilase uso da mesma construção de DNA vetor de express o recombinante célula processos para produzir uma &-amilase hibrida e para preparar uma variante de uma &-amilase aditivo detergente e composições detergentes
EE05519B1 (et) im„„rne glkosleeritud lahustuva interleukiin 6retseptori/interleukiin 6 valk ja selle bioloogiliselt aktiivsed analoogid nende valmistamismeetodja kasutamine DNA j„rjestus DNA vektor transformeeritud imetajarakud ja farmatseutiline komposits
BR9708887A (pt) Variante de uma alfa-amilase uso de mesma construção de dna vetor de expressão recombinante célula aditivo e composição detergente e processo para gerar uma variante de uma alfa-amilase
BR9507229A (pt) Amilase composição detergente aditivo detergente uso de um detergente e de uma amilase construç~o de dna vetor de expressão recombinante célula e processo para produzir amilase
EP1067949A4 (en) SEQUENCE AND METHOD FOR THE GENETIC PRODUCTION OF PROTEINS HAVING CELL MEMBRANE TRANSLOCATION ACTIVITY
NO982672L (no) FremgangsmÕte for fremstilling av rekombinante proteiner i E. coli ved fermentering med h°y celletetthet
EP0953041A4 (en) SERUM-FREE CULTURAL MEDIUM FOR MAMMAL CELLS AND THEIR USE
ID21859A (id) Bahan lembaran serupa-kulit dan metode untuk memproduksi bahan tersebut
AU9582398A (en) Methods and devices for the long-term culture of hematopoietic progenitor cells
HUP0001937A2 (hu) Új vegyületek, eljárás előállításukra és alkalmazásuk nukleinsavak sejtekbe való bevitelére
DE69731400D1 (de) Proliferation humaner endokriner pankreaszellen in kultur
AU7719596A (en) Adenovirus-mediated production of bioactive proteins by mammalian cells and animals
AU1870597A (en) Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
AU1873097A (en) Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
AU3982497A (en) Double-stranded rna dependent protein kinase derived peptides to promote proliferation of cells and tissues in controlled manner
FR2732978B1 (fr) Vecteur viral recombinant, composition pharmaceutique le contenant et cellules transformees correspondantes
WO2000006713A8 (en) Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
BR9400600A (pt) Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos

Legal Events

Date Code Title Description
PC Transfer

Free format text: NOVOZYMES A/S (DK)

EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal